TACK SHS: Tackling tobacco-related chronic diseases in Europe: 8_october_tackshs_icolc.docx Novel data from the Horizon 2020 TackSHS project reveals the results of exposure to secondhand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from electronic cigarettes on the respiratory health of European population, the burden of associated mortality and morbidity, and economic consequences for national and European welfare. Press release from final conference.
New Irish research shows “Allen Carr” is successful for smoking cessation: New study has just been published in the BMJ’s Tobacco Control journal which shows results of the first published Randomised Clinical trial in the world demonstrating that Allen Carr ‘s Easyway to stop smoking is a highly effective treatment to help smokers quit. Full Paper available here.
TFRI deliverable 'Development of policy recommendations' used the empirical evidence generated in the project to develop recommendations for the prevention of youth smoking. More detailed recommendations can be found here.
Youth turning to cheaper Roll Your Own Tobacco Products: Newspaper Link
Tobacco Free Ireland (‘TFI’), the report of the Tobacco Policy Review Group, was endorsed by Government and published in October 2013. An Action Plan for TFI was published in March 2015 and one of its actions committed the Department of Health to publish an annual report on the implementation of the Plan.Considerable progress was made in 2017 in implementing the Action Plan as set out in detail in the Annual Report.
TOB-g project launched its e-learning course November 2017. The Tob-g e-course constitutes a key part of this important project. This course is based on the structure and material of the Tob-g guidelines. Its aim is to provide an individualised approach to smoking cessation within five clearly distinctive sub-populations of smokers, who obviously cannot continue to be treated as a single entity. Teenagers, cardiovascular patients, pregnant women, patients with diabetes and chronic obstructive pulmonary disease (COPD) belong to clearly distinct groups and reasonably so require a tailored approach to treatment.
The first new building to be constructed on the Dublin Institute of Technology Grangegorman campus has been opened.The Greenway Hub will be home to the institution’s postgraduate researchers as well as those commercialising their research and growing spin-out companies. The 5-storey €17 million euro building will host DIT’s Environmental Sustainability and Health Institute (ESHI) with researchers working in areas like vision science, food and water quality, energy, bio monitoring and diagnostics, and health policy development. More news:
ESPAD Ireland 2015 published, 20th September, 2016 Ireland’s 2015 report on the European Schools Project on Alcohol & other Drugs in Ireland (ESPAD) finds a dramatic reduction in teenage drinking and smoking but concerns over e-cigarettes, drugs and gambling. Smoking and drinking among 15-16 year-old school students are falling dramatically, but challenges posed by illicit drug use remain. In this age group, Ireland has much lower levels of drinking, binge drinking and smoking than the European average, but higher use of cannabis, inhalants and other drugs. Find out more here.
European Court of Justice upholds Tobacco Products Directive:Great news from the European Court of Justice – all three challenges against the EU Tobacco Products Directive were rejected today May 4th 2016. The Court rejected the challenge brought by Philip Morris and British American Tobacco which sought to invalidate the TPD as a whole, or alternatively various provisions of the Directive including, inter alia, mandatory large pictorial warnings, the ban on characterising flavours and measures concerning tracking and tracing.
An assessment of the economic costs of smoking in Ireland: Key findings: It is estimated that smoking causes 5,870 deaths per annum with an additional 92 per annum as a result of exposure to second hand smoke (SHS). This is an increase from an estimated 5,200 deaths per annum previously calculated, the increase is due to more cancers and respiratory diseases being attributable to smoking than heretofore. Healthcare costs The estimated cost to the healthcare system as a result of smoking is over a half a billion euro (€506 million) as outlined below: · Hospital based costs €211 million · Primary care costs €256 million · Domiciliary care costs €40 million.